glp 1 ckd Kidney and Cardiovascular Outcomes Among Patients With Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials The expanding benefits of GLP-1
Description
"Given the growing body of anecdotal and clinical evidence, I would strongly support expanded research into GLP-1 receptor agonists as a therapeutic tool for addiction
However, severity and tolerance vary widely from person to person
In practical terms, low energy availability may contribute to: Slower muscle and tendon remodeling Reduced tolerance to training volume Delayed strength progression during rehabilitation Higher perceived fatigue Increased risk of overuse symptoms Longer timelines to return to sport at full performance capacity For physical therapists and sports medicine clinicians, this matters more than ever
(September 2022)
Carter BA, Cohran VC, Cole CR, Corkins MR, Dimmitt RA, Duggan C, et al
Acta Psychiatr Scand
